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Temporal and seasonal trends in Campylobacter genotypes causing human gastroenteritis were investigated in a 6-year study of
3,300 recent isolates fromOxfordshire, United Kingdom. Genotypes (sequence types [ST]) were defined using multilocus se-
quence typing and assigned to a clonal complex (a cluster of related strains that share four or more identical alleles with a previ-
ously defined central genotype). A previously undescribed clonal complex (ST-464) was identified which, together with ST-42,
ST-45, and ST-52 complexes, showed increasing incidence. Concurrently, the incidence of ST-574, ST-607, and ST-658 com-
plexes declined. The relative frequencies of three clonal complexes (ST-45, ST-283, and ST-42) peaked during summer and those
of two (ST-353 and ST-403) peaked during winter. Nine clonal complexes (ST-22, ST-45, ST-48, ST-61, ST-257, ST-283, ST-403,
ST-658, and ST-677) were significantly associated with ciprofloxacin sensitivity (P< 0.05). Seven clonal complexes (ST-49, ST-
206, ST-354, ST-446, ST-460, ST-464, and ST-607) were associated with ciprofloxacin resistance (P< 0.05). Clonal complexes
exhibited changing incidence and differences in seasonality and antibiotic resistance phenotype. These data also demonstrated
that detailed surveillance at a single site captures information which reflects that observed nationally.
Campylobacter jejuni and Campylobacter coli are the most fre-quent causes of acute bacterial gastroenteritis in humans, rep-
resenting an unrelenting worldwide public health problem. C. je-
juni accounts for over 90% of cases, with the majority of the
remainder caused by C. coli (14). The annual incidence of diag-
nosed human infections in 2008 was 92 per 100,000 individuals
(16) in England and Wales, compared to 13 per 100,000 in the
United States (4). However, estimates of underreporting indicate
that the actual incidences are 7- and 38-fold higher, respectively
(4, 47). Incidence varies with age, being highest among those un-
der five years of age (16), and overall, males are more frequently
affected, with a male-to-female sex ratio of 1.2 to 1 (28). Many
wild and farmed avian andmammalian species carry campylobac-
ters as commensal members of the gastrointestinal microbiota,
with human infection resulting from either direct contact with
contaminated feces or indirect transmission via contaminated
food.
Multilocus sequence typing (MLST) studies have determined
C. jejuni and C. coli population structures to be essentially non-
clonal but comprising a large number of genetically related iso-
lates, or clonal complexes (8, 10). Outbreak investigation (39),
case control (35), and “natural” experiments (46, 50) have impli-
cated contaminated poultry meat as a major cause of clinical in-
fection. These findings have been strongly supported by source
attributionmodels that have employedMLST data to estimate the
contribution made by different potential infection sources to the
burden of human disease (41, 42). While emphasizing the impor-
tance of contaminated poultry in this regard, these analyses also
support a role for bovine, ovine, and other sources (7, 41, 42).
Reports from various temperate countries have shown that the
incidence of human campylobacteriosis is at its highest consis-
tently during the same week each year, although this time point
shows variation among countries (26, 28, 38). This pronounced
seasonalitymay be coincident with increasedCampylobacter prev-
alence in reservoirs for infection and seasonal changes in human
behavior that affect exposure (38). Variation in the prevalence of
Campylobacter in various reservoirs has been found in some stud-
ies to correspond to the seasonal pattern of human campylobac-
teriosis (44), but this finding has not been universal (18). Seasonal
variation in the incidence of human infection caused by certain
clonal complexes has been described, notably increased inci-
dences of sequence type 45 (ST-45) and ST-283 complex during
the early summer (29, 43).
As human Campylobacter infection is generally self-limiting,
antimicrobial therapy is not routinely recommended in the
United Kingdom, but where symptoms are severe or prolonged,
ciprofloxacin and clarithromycin are the treatments of choice (1).
In Oxfordshire, United Kingdom, the proportion of clinical cip-
rofloxacin-resistant Campylobacter isolates increased from 3% in
1991 to 37.5% in 2008 (5). Resistance levels of 30 to 50%have been
reported in Cambodia (2006) (30), 23.0% in the United States
(2009) (49), and 71.4% in rural India (2002) (20), and more re-
cently the level was 97.9% in China (17). An association between
poultry consumption and acquisition of ciprofloxacin-resistant
Campylobacter has been described, and some studies have de-
tected possible associations between clonal complex and antibi-
otic resistance (15, 24). In Australia, where these drugs have not
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been approved for use in food-producing animals, levels of fluo-
roquinolone resistance remain low (48).
Here, MLST was used (8, 10) to study genotypes causing
Campylobacter infection in a defined human population (ap-
proximately 640,000 individuals in 2009, corresponding to ap-
proximately 1% of the total United Kingdom population) liv-
ing in the catchment area of the Clinical Microbiology
Laboratory, John Radcliffe Hospital, Oxfordshire, United
Kingdom. These data permitted the investigation of clonal
complex seasonality and ciprofloxacin resistance. Additionally,
the data (available at http://pubmlst.org/perl/bigsdb/bigsdb.pl
?dbpubmlst_campylobacter_isolates) provided a baseline to
inform on the impact of proposed interventions intended to
reduce Campylobacter infection rates in England and Wales
and provided a comparator for other human and veterinary
Campylobacter epidemiological studies.
MATERIALS AND METHODS
Isolates. The Campylobacter isolates included in this study were cultured
from human stool samples submitted to the Clinical Microbiology Labo-
ratory, Oxford University Hospitals NHS Trust, Oxford, United King-
dom, between 15 September 2003 and 14 September 2009. The specimens
were from both hospital and community subjects. The size of the popu-
lation served is approximately 640,000, representing around 1% of the
United Kingdom population. Fecal samples were emulsified in cysteine
selenite broth, plated ontoCampylobacter blood-free selective agar (E&O
Laboratories Limited, Bonnybridge, United Kingdom), and incubated at
42°C for 48 h under microaerophilic conditions. Bacterial colonies iden-
tified as oxidase-positive, catalase-producing, curved Gram-negative
rods, with typical colonial morphology when subcultured to blood agar,
were reported as Campylobacter species.
For long-term storage, isolates were emulsified in Luria broth contain-
ing 5% glycerol and stored at 80°C. The susceptibilities of the Campy-
lobacter isolates to ciprofloxacin (1 g) and erythromycin (5 g) were
determined using amodified Stokes disk diffusionmethod (Becton,Dick-
inson, Oxford, United Kingdom) (2). For isolates with reduced zones, the
MIC was determined by Etest (bioMérieux Clinical Diagnostics). The
method was subject to internal and external quality assurance (National
External Quality Assessment Service [NEQAS]) with satisfactory perfor-
mance. The isolation date was recorded for each isolate, together with
corresponding anonymized details of patient age, sex, and recent travel
outside the United Kingdom.
Multilocus sequence typing. Bacterial DNA samples were produced
from cultured Campylobacter cells suspended in molecular biology-grade
water (125 ml; Sigma-Aldrich Company Ltd., Dorset, United Kingdom).
The suspension was vortex mixed briefly and heated at 100°C for 10 min,
debris was removed by centrifugation at 13,000  g for 10 min, and the
supernatant, containing chromosomal DNA, was removed and stored at
20°C. When further DNA template was required, isolates were recul-
tured on Columbia blood agar plates (Oxoid Ltd., Basingstoke, United
Kingdom) and incubated at 42°C for 48 h under microaerophilic condi-
tions.
Multilocus sequence typing was performed as described previously (8,
10, 32). Briefly, PCR amplification of the seven housekeeping loci was
performed using either oligonucleotide primers designed to amplify the
relevant loci frombothC. jejuni andC. coli isolates (32) or those described
previously (8, 10). Amplification products were purified by precipitation
with 20% polyethylene glycol-2.5 M NaCl (11), and nucleotide sequenc-
ing was performed at least once on each DNA strand using the PCR prim-
ers and BigDye ready reaction mix (version 3; Applied Biosystems, Foster
City, CA). Previously described and newly identified alleles, sequence
types (ST), and clonal complexes were assigned by querying the MLST
database located at http://pubmlst.org/campylobacter/ (21), which held
details of 88,859 sequences, 5,705MLST profiles, and 13,069 isolates as of
9 January 2012. Potential central genotypes of emergent or previously
undescribed clonal complexes were identified by their frequency within
the data set and the pubMLSTdatabase. Candidate central genotype allelic
profiles were then tested for the presence of single-, double-, and triple-
locus variants in the pubMLST database, and clonal complex members
sharing four or more identical alleles with the putative central genotype
were identified with the BURST algorithm, available at the website de-
tailed above.
Statistical analyses. Frequency distributions of continuous or cate-
gorical variables within populations were compared by either the t test,
Pearson’s chi-square statistic, or, where sample sizes were small, Fisher’s
exact test. These and logistic regression analyses of secular and seasonal
trends of clonal complexes were carried out using StataIC 10 (StataCor-
pLP, Texas). Genetic differentiation between populations was assessed
using Fst pairwise comparisons of concatenated sequences for the seven
MLST alleles with ARLEQUIN software version 3 (12). The diversity of
STs within and between clonal complexes among populations was as-
sessed using amodified version of Simpson’s index of diversity (19), based
on the probability of two unrelated strains being of the same type.
RESULTS
Isolates.A total of 4,291Campylobacter isolates, each representing
a unique infection, were cultured between September 2003 and
September 2009. Isolates were genotyped by MLST, and the ST
was determined for 3,300 (76.9%) (Table 1). The STs were used to
identify isolates to the species level (41): 91.6% were C. jejuni and
8.4% C. coli. The remaining 991 isolates were partially typed or
untyped due to loss of viability during storage. Comparison of
patient demographic data (sex, age, and month of isolation) and
isolate antibiotic resistance data (ciprofloxacin and erythromy-
cin) for the total isolates (4,291) versus isolates with complete
allelic profiles (3,300) confirmed that the genotyped cases were
representative of the collection. Subsequent analyses include only
the 3,300 cases for which the ST of the Campylobacter isolates was
determined.
Age, sex, and seasonal distribution of cases.The age distribu-
tion of the 3,300 cases stratified by year of age was examined. The
highest rates of illness occurred in children under two and young
adults (Fig. 1A). The sex distribution of cases within the John
Radcliffe Hospital Microbiology Laboratory catchment area was
examined by 5-year age group. The proportion of illness in males
was greater in all groups except those aged 75 to 79 years and
individuals over 85 years of age, where numbers of cases in females
were higher, and those aged 15 to 19, where no sex bias was ob-
served (Fig. 1B). The seasonal distribution of cases showed a
marked summer peak (Fig. 2).
MLST and clonal complexes. The 3,300 isolates comprised
368 C. jejuni and 70 C. coli STs, each of which was assigned to a
TABLE 1 Summary of isolates genotyped over the 6-year study period
Yr of study
No. (%) of isolates
Unique
Assigned to
sequence
type
Assigned to
clonal
complex
September 2003–September 2004 584 575 (98.5) 530
September 2004–September 2005 637 531 (83.4) 495
September 2005–September 2006 680 537 (79.0) 496
September 2006–September 2007 841 613 (72.9) 560
September 2007–September 2008 778 468 (60.2) 408
September 2008–September 2009 771 576 (74.7) 503
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FIG 1 Age distribution ofCampylobacter cases in the John Radcliffe Hospital catchment area, Oxfordshire, United Kingdom, betweenmid-September 2003 and
mid-September 2009. (A) Incidence of infection per 1,000 individuals; (B) incidence among females () and males () per 1,000 age-related individuals.
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clonal complex using http://pubmlst.org/campylobacter. A total
of 157 (26.8%) STs could not be assigned to a previously defined
clonal complex; 137 were C. jejuni, and 20 were C. coli. These
unassigned STs were investigated for the presence of undescribed
central genotypes, leading to the identification of the C. jejuni
ST-464 complex, containing eight STs and 71 isolates. In total, 35
C. jejuni clonal complexes and 1 C. coli clonal complex (ST-828
complex) were present within the data set, with 149 (25.4%) STs
remaining unassigned. Six clonal complexes (ST-21, ST-257, ST-
828, ST-45, ST-48, and ST-443 complexes) represented 59.8% of
all isolates, ranging from 22.8% to 5.3%, respectively (Fig. 3). In
total,C. coli belonging to the ST-828 complex or unassigned to an
ST comprised 8.4% of isolates.
Temporal trends in clonal complexes.The temporal distribu-
tion of the 20most abundant clonal complexes was analyzed using
logistic regression analysis, which identified a year-on-year in-
crease in the number of isolates assigned to ST-42, ST-45, ST-464,
and ST-52 clonal complexes, whereas isolates belonging to ST-
574, ST-607, and ST-658 complexes decreased in incidence over
the study period. The overall trends were summarized as odds
ratios representing the average increase or decrease in probability
of an isolate belonging to that clonal complex per year of the study
(Table 2). Although these seven clonal complexes do show an
overall linear trend across the 6-year period, none are monotonic
and there are substantial year-to-year variations, which in some
cases (ST-42, ST-45, and ST-607 complexes) equal or exceed the
overall change from year 1 to year 6.
Seasonality of clonal complexes. The data were examined for
seasonal variation in the clonal complexes that occurred during
the summer peak in incidence (June to September), compared to
those that occurred during the rest of the year, using Pearson’s
chi-square test. The composition of clonal complexes that oc-
curred between June and September was significantly different
from that which occurred during the rest of the year (P value with
the chi-square test [2 P] 0.001).
A logistic regressionmodelwas thenused to identify significant
seasonal trends for individual clonal complexes. Isolates belong-
ing to ST-283, ST-42, and ST-45 complexes peaked as a propor-
tion of the total during June and July (P 0.013, P 0.018, and
P  0.001, respectively) (Fig. 4). ST-353 and ST-403 complexes
(P 0.005 and P 0.021, respectively) were proportionally most
prevalent during November. Variation that deviated from overall
harmonic seasonal patterns was detected for the ST-257 complex
(2 P  0.008), which was lower than expected in July and No-
vember, and for the ST-354 complex (2P 0.001), which peaked
in November (data not shown).
Antibiotic resistance and clonal complex. Following primary
culture, 3,262 isolates (98.9%) were examined by disk diffusion
FIG 2 Seasonality of human Campylobacter genotyped isolates from the John Radcliffe Hospital catchment area, Oxfordshire, United Kingdom, between 2003
and 2009.
Cody et al.
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for sensitivity to ciprofloxacin (1 g) and 3,265 (98.9%) isolates
for sensitivity to erythromycin (5 g). The proportion (percent-
age) of all ciprofloxacin-sensitive isolates (2,243; 69.8%) and all
resistant isolates (972; 30.2%) associatedwith each of the 25 clonal
complexes represented 10 times or more in the data set was deter-
mined. Isolates unassigned to a clonal complexwere considered as
a separate group for each species. Equivalent calculations were
made for erythromycin-sensitive (3,167; 98.2%) and -resistant
(57; 1.8%) isolates.
Nine clonal complexes (ST-22, ST-45, ST-48, ST-61, ST-257,
ST-283, ST-403, ST-658, and ST-677) were significantly associ-
ated with ciprofloxacin sensitivity (P 0.05) (Table 3), and seven
clonal complexes (ST-49, ST-206, ST-354, ST-446, and ST-460,
along with the newly described ST-464 and ST-607 complexes)
were significantly associated with ciprofloxacin resistance, as were
unassigned C. jejuni STs. One clonal complex (ST-257) was sig-
nificantly associated with erythromycin-sensitive isolates,
whereas the only significant association between either of the an-
tibiotics and C. coli isolates was that between both ST-828 com-
plex and unassigned C. coli STs with erythromycin resistance.
Patients reporting recent travel outside the United Kingdom
(n  381) were five times more likely to have a ciprofloxacin-
resistant Campylobacter than those who had not (2 P  0.001).
No difference in the proportion of erythromycin-resistant isolates
was detected between travelers and nontravelers.
Patient demographics and genotype. The MLST and clonal
complex data for each of the 3,300 isolates were examined to de-
tect associations among infecting genotype and patient age, gen-
FIG3 Relative proportion of clonal complexes representedmore than 10 times in the data set in decreasing order of abundance. UA indicates sequence types that
are not assigned to a clonal complex. Isolates belonging to C. coli, indicated by white bars, either were assigned to the ST-828 complex or belonged to sequence
types unassigned to a clonal complex.
TABLE 2 Overall trends and odds ratiosa
Clonal complex
% of isolates in complex
Odds ratiob P value CIcYr 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr 6
ST-42 1.6 0.6 0.6 1.3 1.7 2.4 1.227 0.02 1.033–1.459
ST-45 6.8 6.6 8.5 4.9 7.9 8.7 1.087 0.03 1.008–1.172
ST-52 0.5 0.8 1.7 1.8 1.3 2.1 1.218 0.025 1.025–1.447
ST-464 0.9 0.4 1.7 1.3 3.2 5.6 1.612 0.001 1.367–1.877
ST-574 5.2 3.2 2.4 3.3 1.7 2.4 0.846 0.004 0.754–0.948
ST-607 1.4 2.7 1.7 0.7 0.4 1.0 0.818 0.025 0.686–0.976
ST-658 2.6 2.3 1.7 1.8 0.9 1.2 0.824 0.012 0.708–0.959
a Overall trends and odds ratios representing the average increase or decrease in probability of an isolate belonging to that clonal complex per year of the study.
b Changing odds per year.
c 95% confidence interval.
Human Campylobacter Epidemiology
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der, and recent travel outside the United Kingdom. Seven 10-year
age groups and an eighth, comprising individuals aged 70 or over,
were used to segregate the STs. Simpson’s index of diversity was
calculated for each group (see Fig. S1 in the supplemental mate-
rial). This revealed no difference in the genotypic diversity of iso-
lates infecting each group (diversity index [DI], 0.973 to 0.980).
Similarly, differences in nucleotide content as indexed by FST val-
ues calculated from concatenated nucleotide sequences of the
MLST loci indicated that the maximum level of sequence differ-
entiation between the STs of each 10-year age group was1%.
Clonal complexes affecting males and females were similar (2
P 0.338), as were the levels of nucleotide sequence diversity for
isolates infecting both genders (maleDI, 0.975 to 0.979; femaleDI,
0.973 to 0.978). Recent travel outside the United Kingdom was
reported by 11.5%of individuals, isolates fromwhombelonged to
clonal complexes that were significantly different (P  0.001)
from those from subjects who had not recently been abroad.
DISCUSSION
Sequence-based characterization, and especially MLST, of Cam-
pylobacter isolates has become the principal tool for understand-
ing the molecular epidemiology of this important pathogen (10).
Such studies have established that although genetically diverse,
Campylobacter populations are highly structured and that the
clonal complex is an informative unit of analysis (9). A key insight
has been that particular clonal complexes are associated with the
colonization of certain host species, which has permitted the ge-
netic attribution of cases of human disease to likely infection
sources and in so doing has principally implicated retail chicken
meat products in a variety of settings (34, 42, 52). Longitudinal
surveillance of the genotypes of human clinical isolates therefore
provides a means of monitoring changes in infection sources or
the appearance of new disease-associated Campylobacter geno-
types. The present 6-year study examined temporal and seasonal
trends in the nature and properties of the Campylobacter clonal
complexes responsible for human disease in a defined, centrally
located United Kingdom region (Oxfordshire) which represents
approximately 1% of United Kingdom residents.
Patterns of age-related illness and gender bias within the pres-
ent study were largely as reported for England and Wales (16). In
common with similar studies of human infection (31, 33, 41, 43),
the Campylobacter genotypes responsible for human disease were
highly diverse, with a predominance of genotypes similar to those
seen previously. However, investigation of isolates having an ST
unassigned to a clonal complex identified 62 isolates of ST-464.
This ST was first submitted to the pubMLST Campylobacter iso-
late database from a human isolate cultured in Japan in 2001. A
further 29 ST-464 isolates and 54 isolates representing 47 single-,
double-, and triple-locus variants of this ST have since been sub-
mitted to the database from Canada, China, Europe, Japan, and
Thailand (January 2012). Furthermore, ST-464 was isolated from
chicken breast meat in the United States in 2002 (51) and ST-464
together with single-, double-, and triple-locus variants from ei-
ther chicken or human stools in Northern China between 2003
and 2008 (53). On the basis of the above data, ST-464was assigned
as the central genotype of a novel clonal complex. Furthermore,
these findings illustrate that the global diversity of Campylobacter
isolates responsible for human disease remains incompletely un-
derstood.
There was evidence for temporal changes in the clonal com-
plexes causing human disease over the 6-year study period: four
clonal complexes (ST-42, ST-45, ST-52, and ST-464) increased in
relative incidence, whereas three complexes (ST-574, ST-607, and
ST-658) decreased (Table 2). The ST-42 complex has been re-
ported to be mainly isolated from ruminants, ST-45 complex
from chicken, wild bird, and environmental sources (6, 13, 41,
44), and ST-464 complex predominantly from chickens (21, 51,
53), while the ST-52 complex has a less well-defined host range.
Both ST-574 and ST-607 complex isolates are largely chicken as-
sociated (21, 41). Therefore, changes in the relative incidence of
different clonal complexes did not provide any evidence for
changing importance of different reservoirs of human infection.
The annual periodicity observed was typical of temperate regions,
with a marked summer peak in human disease incidence between
June and September (Fig. 3) (26, 38). The most prevalent clonal
complexes overall were ST-21, ST-257, ST-828, ST-45, ST-48, and
FIG4 Seasonal and longer-term trends observed using a harmonic regressionmodel of the data for clonal complexeswhose frequency as a proportion of the total
incidence were significantly higher during summer (ST-45, ST-283, and ST-42 complexes) or winter months (ST-353 and ST-403 complexes).
Cody et al.
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ST-443 (Fig. 3), which were also among the most frequently iso-
lated, and of comparable incidence with those in a similar-sized
study of human campylobacteriosis in Scotland from 2005 until
2006 (41). These data therefore established that detailed surveil-
lance at a single sentinel surveillance site captures information
that reflects that observed nationally.
Evidence of seasonality contributing significantly to the sum-
mer peak in disease incidence was observed for three clonal com-
plexes; ST-45 (June), ST-283 (July), and ST-42 (July). This pattern
has been reported previously for ST-45 (22, 29, 44) and ST-283
complexes (29) but not for the ST-42 complex. The ST-45 and
ST-283 complexes have both been identified as chicken associated
(7, 21, 41), and the ST-45 complex has additionally been identified
from a wide range of wild animal sources (27), but the ST-42
complex has been predominantly associated with ruminant hosts
(6, 13, 21). While MLST data for isolates belonging to ST-45 and
ST-283 complexes confirms a recent common ancestor (29), no
similarity in genotype or host association was observed between
these two complexes and isolates belonging to the ST-42 complex.
The present study identified two clonal complexes (ST-353 and
ST-403) that peak in relative incidence during thewinter (Novem-
ber). The former is predominantly isolated from chickens, as well
as cases of human infection, but the latter has a much wider host
range which largely excludes poultry (21, 41). The basis for their
shared seasonal pattern is therefore unclear anddoes not appear to
be associated with a shared host. Seasonal differences are likely to
reflect the Campylobacter genotypes that are present in the food
chain or, possibly, exposure of the human population to different
infection sources.
Rapidly increasing fluoroquinolone resistance in Campylobac-
ter strains causing human disease is a matter of public health im-
portance as has been noted previously in the Oxfordshire data set
(5). Themean values for ciprofloxacin (30.1%) and erythromycin
(1.7%) resistance phenotypes over the 6-year period were similar
to those recently reported (5, 25), although even higher levels of
fluoroquinolone resistance have been observed (17, 20, 30). Sim-
ilarly, higher rates of ciprofloxacin-resistant isolates among pa-
tients reporting recent travel outside the United Kingdom con-
firm a previous study (37). The poultry production industry is
often seen as themajor source of antimicrobial resistance inCam-
pylobacter (36).There was a statistically significant association
between ciprofloxacin resistance and seven C. jejuni clonal com-
plexes; ST-49, ST-206, ST-354, ST-446, ST-460, ST-464, and ST-
607 (Table 3). Previous reports have identified an association be-
TABLE 3 Clonal complexes represented by 10 or more isolates, demonstrating a nonrandom association with antibiotic sensitivity or resistance as
determined by Pearson’s 2 or Fisher’s exact testc
Clonal complex
Ciprofloxacin Erythromycin
Sensitive Resistant
P value
Sensitive Resistant
P value
No. of
isolates %
No. of
isolates %
No. of
isolates %
No. of
isolates %
ST-21 complex 531 71.5 212 28.5 0.250 731 98.4 12 1.6 0.718
ST-22 complex 39 84.8 7 15.2 0.026 46 100 0 0 1a
ST-42 complex 35 77.8 10 22.2 0.274 45 100 0 0 1a
ST-45 complex 213 90.6 22 9.4 0.001 229 97.5 6 2.6 0.366
ST-48 complex 182 82.7 38 17.3 0.001 215 97.7 5 2.3 0.556
ST-49 complex 8 47.1 9 52.9 0.041 17 100 0 0 1a
ST-52 complex 29 64.4 16 35.6 0.434 45 100 0 0 1a
ST-61 complex 57 93.4 4 6.6 0.001a 62 100 0 0 0.628a
ST-206 complex 80 59.7 54 40.3 0.010 133 99.3 1 0.8 0.731a
ST-257 complex 275 84.9 49 15.1 0.001 323 99.7 1 0.3 0.041a
ST-283 complex 34 91.9 3 8.1 0.002a 37 100 0 0 1a
ST-353 complex 94 67.6 45 32.4 0.574 138 99.3 1 0.7 0.516a
ST-354 complex 28 21.4 103 78.6 0.001 131 100 0 0 0.172a
ST-403 complex 31 91.2 3 8.8 0.004a 34 100 0 0 1a
ST-443 complex 122 70.1 52 29.9 0.918 170 97.1 5 2.9 0.261
ST-446 complex 3 21.4 11 78.6 0.001a 13 92.9 1 7.1 0.221a
ST-460 complex 4 36.4 7 63.6 0.023a 11 100 0 0 1a
ST-464 complex 14 20.6 54 79.4 0.001 67 98.5 1 1.5 1a
ST-573 complex 13 86.7 2 13.3 0.257a 15 100 0 0 1a
ST-574 complex 63 61.8 39 38.2 0.074 102 100 0 0 0.262a
ST-607 complex 18 42.9 24 57.1 0.001 42 97.7 1 2.3 0.538a
ST-658 complex 48 82.8 10 17.2 0.030 58 100 0 0 0.626a
ST-661 complex 19 82.7 4 17.4 0.254a 23 100 0 0 1a
ST-677 complex 11 100 0 0.0 0.041a 11 100 0 0 1a
ST-828 complexb 170 65.9 88 34.1 0.158 245 95.0 13 5.0 0.001
UA C. jejuni STs 112 53.5 97 46.4 0.001 208 96.7 7 3.3 0.087
UA C. coli STsb 10 52.6 9 47.4 0.103 16 84.2 3 15.8 0.004a
Total 2,243 972 3,167 57
a Values calculated using Fisher’s exact test (values without this superscript were calculated using Pearson’s chi-square test).
b C. coli isolates.
c Underlined values have statistically significant P values. Data were calculated with Pearson’s chi-square test unless noted otherwise. UA, sequence types unassigned to a clonal
complex.
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tween ST-21, ST-206, ST-353, and ST-354 complexes and
ciprofloxacin resistance (15, 24, 25, 51), although each of these
investigations included fewer than 200 geographically diverse iso-
lates. Furthermore, variation occurred between studies in the
methodology and breakpoints used to define ciprofloxacin-resis-
tant strains. Eight of the clonal complexes associated with cipro-
floxacin resistance have not been associated with a single reservoir
of infection, two (ST-354 and ST-464) are chicken associated (41,
51, 53), and one (ST-206) is predominantly isolated from rumi-
nants (41). Of nine clonal complexes associated with ciprofloxa-
cin sensitivity, two (ST-257 and ST-283) are chicken associated
(40) and one (ST-45) has been isolated from a variety of hosts,
including poultry (41, 44).
These results suggest a complex acquisition pathway and raise
the question whether the food industry, or one subset of it such as
poultry production, is a dominating influence in the distribution
of ciprofloxacin resistance among campylobacters. Levels of resis-
tance to erythromycin remained static and low (2%) through-
out the study, and the only associations observed were between
erythromycin resistance and C. coli isolates and between ST-257
complex and erythromycin sensitivity, the former in agreement
with reports from others (51). However, unlike fluoroquinolones,
the fitness cost to low-level erythromycin-resistant isolates results
in a lack of stability in the absence of selective pressure (3, 23),
which may in part explain the difference in levels of resistance to
these antibiotics in clinical isolates.
The continuing high burden of human campylobacteriosis re-
mains an unresolved public health problem of high importance.
Genetic attribution studies have identified the principal source of
infection as retail meat, especially chicken, in a number of coun-
tries, including the United Kingdom. Molecular data have led to
interventions in the poultry industry in New Zealand which have
proved to be effective in reducing human disease (40); however,
New Zealand poultry production is limited to three major suppli-
ers (33) and the extent to which this will be possible in countries
withmore complex industries remains unclear. In any case, ongo-
ing surveillance of the genotypes causing human disease is essen-
tial if the impact of such interventions is to be measured and
understood, particularly as the predominant genotypes in human
disease show pronounced changes over time and new genotypes
are frequently observed, reflecting the size and diversity of the
Campylobacter populations that infect chickens. The present
study demonstrates that such surveillance is feasible. In a country
such as the United Kingdom where nationally distributed foods
are themajor source of infection, this can be achieved by intensive
surveillance at relatively few sites.
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